MBD4 and polyposis: In contrast to findings with uveal melanoma where heterozygotes for MBD4 LOF variants appear to be at a 4- to 20-fold increased risk, our limited data show no convincing evidence for a comparable effect on the relative risk of developing polyposis and/or CRC.